The launch of the Alli® pill has fueled discussions and controversy for several months now, but it is only from this Wednesday, May 6 that it is officially on sale in pharmacies. This drug against overweight and obesity dispensed without a prescription – this is the whole point of this marketing – is intended for people whose Body mass index (BMI) is equal to or greater than 28kg / m2.
Responsibility for the pharmacist to give Alli® only to the patients concerned. Despite the training and information system for professionals set up by the GlaxoSmithKline laboratory, opponents of Alli® fear possible abuses, especially since there are contraindications to taking this drug and side effects. very inconvenient. Its supporters believe that it is one more weapon in the fight against excess weight and associated diseases.
To learn more about Alli®, click here!